CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 31, 2017--
Pharmaceuticals, Inc. (NASDAQ:RARX), a clinical stage
biopharmaceutical company focusing on the development of next-generation
therapeutics for the treatment of complement-mediated diseases, today
announced that Doug Treco, PhD, President and Chief Executive Officer,
will present at the Jefferies 2017 Global Healthcare Conference on
Wednesday, June 7, 2017 at 2:30 p.m. E.T.
The presentation will be webcast live and can be accessed by visiting
the investor relations section of the Company’s website, www.rapharma.com.
A replay of the presentation will also be available and archived on the
site for three weeks.
About Ra Pharmaceuticals
Ra Pharmaceuticals is a clinical stage biopharmaceutical company
focusing on the development of next-generation therapeutics for
complement-mediated diseases. The Company discovers and develops
peptides and small molecules to target key components of the complement
cascade. For more information, please visit: www.rapharma.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170531005245/en/
Source: Ra Pharmaceuticals, Inc.
Ra Pharmaceuticals, Inc.
Eliza Schleifstein, 917-763-8106